Wolverine Trading, LLC Crispr Therapeutics Ag Transaction History

Wolverine Trading, LLC

  • $97.8 Billion
  • Q1 2024

A detailed history of Wolverine Trading, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wolverine Trading, LLC holds 29,487 shares of CRSP stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,487
Previous 19,923 48.0%
Holding current value
$1.59 Million
Previous $1.25 Million 61.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $580,247 - $852,343
9,564 Added 48.0%
29,487 $2.01 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $33,329 - $62,291
863 Added 4.53%
19,923 $1.25 Million
Q3 2023

Nov 15, 2023
BUY
$45.39 - $59.0 $229,628 - $298,481
5,059 Added 36.13%
19,060 $865,000
Q2 2023

Aug 23, 2023
BUY
$43.47 - $67.77 $411,226 - $641,104
9,460 Added 208.32%
14,001 $786,000
Q1 2023

May 15, 2023
SELL
$41.0 - $56.12 $36,285 - $49,666
-885 Reduced 16.31%
4,541 $201,000
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $68,739 - $115,185
1,754 Added 47.77%
5,426 $221,000
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $191,854 - $263,069
-3,140 Reduced 46.1%
3,672 $237,000
Q2 2022

Aug 15, 2022
SELL
$43.23 - $73.83 $701,363 - $1.2 Million
-16,224 Reduced 70.43%
6,812 $429,000
Q1 2022

May 16, 2022
SELL
$53.19 - $79.24 $859,018 - $1.28 Million
-16,150 Reduced 41.21%
23,036 $1.48 Million
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $410,587 - $651,936
5,858 Added 17.58%
39,186 $3.09 Million
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $1.82 Million - $2.58 Million
-16,474 Reduced 33.08%
33,328 $3.67 Million
Q2 2021

Aug 06, 2021
SELL
$100.84 - $161.89 $1.2 Million - $1.93 Million
-11,949 Reduced 19.35%
49,802 $7.5 Million
Q1 2021

May 14, 2021
BUY
$110.72 - $210.04 $3.05 Million - $5.78 Million
27,504 Added 80.31%
61,751 $7.11 Million
Q4 2020

Feb 12, 2021
BUY
$79.67 - $173.23 $1.47 Million - $3.21 Million
18,512 Added 117.65%
34,247 $5.53 Million
Q3 2020

Nov 13, 2020
SELL
$78.5 - $100.64 $488,348 - $626,081
-6,221 Reduced 28.33%
15,735 $1.34 Million
Q2 2020

Aug 13, 2020
BUY
$38.5 - $76.05 $176,445 - $348,537
4,583 Added 26.38%
21,956 $1.65 Million
Q1 2020

May 11, 2020
BUY
$33.68 - $62.53 $128,522 - $238,614
3,816 Added 28.15%
17,373 $769,000
Q4 2019

Feb 12, 2020
SELL
$36.68 - $73.13 $110,553 - $220,413
-3,014 Reduced 18.19%
13,557 $838,000
Q3 2018

Nov 14, 2018
BUY
$44.35 - $65.71 $734,923 - $1.09 Million
16,571 New
16,571 $735,000

Others Institutions Holding CRSP

# of Institutions
549
Shares Held
56.3M
Call Options Held
2.91M
Put Options Held
2.47M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.21B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email